BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22484007)

  • 21. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
    Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
    ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach.
    Hou JQ; Chen SB; Zan LP; Ou TM; Tan JH; Luyt LG; Huang ZS
    Chem Commun (Camb); 2015 Jan; 51(1):198-201. PubMed ID: 25388435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression.
    Agarwal T; Roy S; Chakraborty TK; Maiti S
    Biochemistry; 2010 Sep; 49(38):8388-97. PubMed ID: 20712380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
    Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
    Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of planarity of unfused aromatic molecules on G-quadruplex binding: learning from isaindigotone derivatives.
    Hou JQ; Tan JH; Wang XX; Chen SB; Huang SY; Yan JW; Chen SH; Ou TM; Luo HB; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2011 Sep; 9(18):6422-36. PubMed ID: 21808792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzofuroquinoline derivatives had remarkable improvement of their selectivity for telomeric G-quadruplex DNA over duplex DNA upon introduction of peptidyl group.
    Long Y; Li Z; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioconjug Chem; 2012 Sep; 23(9):1821-31. PubMed ID: 22871222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
    Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
    Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-(1H-imidazo[4,5-f]-1,10-phenanthrolin-2-yl)phenol-based G-quadruplex DNA binding agents: telomerase inhibition, cytotoxicity and DNA-binding studies.
    Wei CY; Wang JH; Wen Y; Liu J; Wang LH
    Bioorg Med Chem; 2013 Jun; 21(11):3379-87. PubMed ID: 23611765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
    Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
    Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter.
    Halder K; Chowdhury S
    Nucleic Acids Res; 2005; 33(14):4466-74. PubMed ID: 16085756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands.
    Jiang Y; Chen AC; Kuang GT; Wang SK; Ou TM; Tan JH; Li D; Huang ZS
    Eur J Med Chem; 2016 Oct; 122():264-279. PubMed ID: 27372288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
    Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
    Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
    Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
    J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA.
    Tian M; Zhang X; Li Y; Ju Y; Xiang J; Zhao C; Tang Y
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):190-9. PubMed ID: 20408050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective recognition of oncogene promoter G-quadruplexes by Mg2+.
    Yan YY; Lin J; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Biochem Biophys Res Commun; 2010 Nov; 402(4):614-8. PubMed ID: 20971074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
    Yin F; Liu J; Deng X; Wang J
    J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The c-MYC NHE III(1): function and regulation.
    González V; Hurley LH
    Annu Rev Pharmacol Toxicol; 2010; 50():111-29. PubMed ID: 19922264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
    Rezler EM; Seenisamy J; Bashyam S; Kim MY; White E; Wilson WD; Hurley LH
    J Am Chem Soc; 2005 Jul; 127(26):9439-47. PubMed ID: 15984871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives.
    Chauhan A; Paladhi S; Debnath M; Dash J
    Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.